Axcelis price target raised to $42 from $32 at Craig-Hallum 08:35 ACLS Craig-Hallum analyst Christian Schwab raised the firm's price target on Axcelis to $42 from $32 and keeps a Buy rating on the shares. The analyst notes that Axcelis positively pre-released its Q4 results ahead of the company's presentation at an investor conference. Following the strong finish to 2020, management expects the mature process technology market to continue to experience growth and for the memory market to experience a recovery in 2021, Schwab adds. The analyst believes this is in line with the view of multiple other semiconductor capital equipment peers, many of which have also positively pre-released the December quarter.
Alright last one NV5- I have forgotton what they do! NV5 Global awarded $15M in infrastructure improvement contracts <-- Something to do with infrastructure and that's good with Biden!! This came up earlier in my scans because-- Over a week ago))) NV5 Global awarded $13M in North Carolina DOT contracts 12/14 NVEE NV5 Global announced that it has been awarded $13M in contracts by the North Carolina Department of Transportation to provide inspection services and feasibility studies. Both contracts have a two-year duration and will support NCDOT transportation projects throughout the state. Within the scope of the $10M Construction Engineering and Inspection contract, NV5's engineers and technicians will perform construction contract administration, inspection, materials sampling, materials testing, documentation, and claims avoidance for various NCDOT projects. Under the $3M Feasibility Studies contract, NV5 will provide express design evaluation, project scoping reports, and feasibility studies that serve as the initial step in the planning and design process for NCDOT transportation projects. And what's more--> They just bought a company yesterday! NV5 Global acquires Industrial Design Associates International 08:07 NVEE NV5 Global announced that it has reached an agreement to acquire Industrial Design Associates International, an international engineering services consulting company. IDA provides building commissioning and MEP design services to clients throughout Asia and Europe. IDA's 85 employees operate out of seven offices in Hong Kong, China, Singapore, and India and specialize in the financial services, data center, and technology markets. Yup...NV5 Global price target raised to $136 from $82 at Roth Capital IT ALL ADDS UP TO BIG BOY ACCOUNT !!!--> NVEE -$91.50
I just ran NVEE through my special series of metrics & cam up with an entry price around $78...... This could be a problem. These building stocks have been on the run for a while... Red Rock Resorts, Inc. (RRR) Sniff Sniff I smell a breakout coming! 26.16+1.32 (+5.31%) At close: January 12 4:00PM EST $26.40+0.24 (0.92%) Before hours:8:00AM EST
Van this RRR is ALL VAN ALL THE TIME. I can't believe after the amount of research I put in here you haven't bought this for your 2021 account. Did you see that pool? This is better quality than what I have seen from these resorts. And we have those views! It's like being on vacation...
Check this out Aug 3rd 2020 VAPO Trades at $52.94 Then just a few days later-- Aug 11th it trades for $ 29!!!!!!!!! Wow. $26-$31 dead man base.... but a pretty long one and now they just beat earnings? Folks this is so hard... I'm leaning towards VAPO NOW!!!!
Vapotherm initiated with an Overweight at Piper Sandler 12/17 VAPO Piper Sandler analyst Jason Bednar initiated coverage of Vapotherm with an Overweight rating and $36 price target. The analyst believes the company can grow revenue 15%-plus sustainably beyond 2021 and expand gross margin by 10-15 points over the next five years. Bednar calls Vapotherm his top small-cap idea and encourages investors to build or add to positions "in this under owned name." The profile on the company's Hi-VNI technology has been raised during COVID and this shift will be lasting, Bednar tells investors in a research note. He believes Hi-VNI will further disrupt the "large and growing" respiratory care market.
Vapotherm remains top small pick at Piper Sandler 08:25 VAPO Piper Sandler analyst Jason Bednar reiterates an Overweight rating on Vapotherm with a $36 price target after the company reported better than expected preliminary Q4 revenue. Demand for Precision Flow throughout the pandemic "has clearly been robust," Bednar tells investors in a research note. He believes this "much larger" user base has helped foster greater clinical appreciation of Vapotherm's technology in advance of key product launches slated for 2021 and positions VAPO "very well to remain a disruptor in treating respiratory distress in the post-COVID years." Vapotherm continues to be Bednar's favorite small-cap name. I'M WACK-O-FOR VAPO!!!!